{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T05:23:55Z","timestamp":1710307435402},"reference-count":7,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2005,8,2]],"date-time":"2005-08-02T00:00:00Z","timestamp":1122940800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostic Cytopathology"],"published-print":{"date-parts":[[2005,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Residual material from liquid\u2010based pap (LBP) test has been used for molecular testing of Human Papilloma Virus (HR HPV) DNA. LBP test specimens (1,025) were evaluated to determine how often residual material was insufficient to perform microbiological testing. The specimens were tested for <jats:italic>Chlamydia trachomatis<\/jats:italic> and <jats:italic>Neisseria gonorrhea<\/jats:italic> (CCGT) alone and in combination with HR HPV(CCGT + HR HPV), using PCR method and HYBRID CAPTURE 2, respectively. A minimum volume of 5 ml (CCGT: 0.5\u20131 ml, HPV: 4 ml) of residual material is required for both the tests. The residual material was measured at &gt;5 ml, \u22645 ml, and 0.5 ml volumes and documented. Results were tabulated. The insufficient rate for cases submitted for CCGT was 0.2% and 7.6% for HR HPV, with a detection rate of 40.9% for HR HPV. Utilizing residual material from LBP test for microbiological testing, as well as DNA testing for HR HPV is a convenient, cost\u2010effective means to enhance patient care. Diagn. Cytopathol. 2005;33:177\u2013180. \u00a9 2005 Wiley\u2010Liss, Inc.<\/jats:p>","DOI":"10.1002\/dc.20325","type":"journal-article","created":{"date-parts":[[2005,8,3]],"date-time":"2005-08-03T20:23:15Z","timestamp":1123100595000},"page":"177-180","source":"Crossref","is-referenced-by-count":10,"title":["Chlamydia\/gonorrhea combo and HR HPV DNA testing in liquid\u2010based pap"],"prefix":"10.1002","volume":"33","author":[{"given":"Clementine M.","family":"Hawthorne","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phillip J.","family":"Farber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marluce","family":"Bibbo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,8,2]]},"reference":[{"key":"e_1_2_1_2_2","unstructured":"Division of Sexually Transmitted Diseases STD Prevention CDC Chlamydia Fact Sheet."},{"key":"e_1_2_1_3_2","unstructured":"Chlamydia Screening and Treatment Programs for Young Women(Online 30 Jan. 2003;http:\/\/www.cdc.gov\/od\/media\/prssre\/chlamyl\/htm)."},{"key":"e_1_2_1_4_2","unstructured":"American Social Health Association \u201cTake Action on HEDIS\u00ae\u201d 2000."},{"key":"e_1_2_1_5_2","unstructured":"U.S. Preventive Services Task Force.Screening for Chlamydia Infection: recommendations and rationale 3rd ed. 2004."},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.40.5.1749-1754.2002"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0749-3797(01)00254-9"},{"key":"e_1_2_1_8_2","unstructured":"PeterV. Chin\u2010Hong JeffreyD. Klausner.Medical Laboratory Observer October 2004 pp.10\u201316. (Dr Klausner is Director STD Prevention San Francisco Department of Public Health.)"}],"container-title":["Diagnostic Cytopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fdc.20325","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/dc.20325","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T06:37:22Z","timestamp":1700203042000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/dc.20325"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8,2]]},"references-count":7,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,9]]}},"alternative-id":["10.1002\/dc.20325"],"URL":"https:\/\/doi.org\/10.1002\/dc.20325","archive":["Portico"],"relation":{},"ISSN":["8755-1039","1097-0339"],"issn-type":[{"value":"8755-1039","type":"print"},{"value":"1097-0339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,8,2]]}}}